Status:
RECRUITING
National Bacterial Meningitis Study
Lead Sponsor:
Association Clinique Thérapeutique Infantile du val de Marne
Collaborating Sponsors:
Pfizer
Conditions:
Meningitis
Children, Only
Eligibility:
All Genders
Up to 18 years
Brief Summary
Bacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibility data. The epidemiology of bacterialm...
Eligibility Criteria
Inclusion
- clinical signs of meningitis, associated with positive cerebrospinal fluid (CSF) culture and/or positive CSF antigen testing (Escherichia coli K1, N. meningitidis serogroups B, A, C, Y and W-135, group B streptococci, Hib, or S. pneumoniae), and/or positive CSF polymerase chain reaction (PCR), and/or positive blood culture with CSF pleocytosis (\> 10 cells/µL).
- purpura fulminans
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
8230 Patients enrolled
Trial Details
Trial ID
NCT04664569
Start Date
January 1 2001
End Date
January 1 2030
Last Update
December 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ACTIV
Créteil, France